<?xml version="1.0" encoding="UTF-8"?>
<ref id="B262-antioxidants-09-01191">
 <label>262.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Heyninck</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Sabbe</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chirumamilla</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Szarc vel Szic</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Vander Veken</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Lemmens</surname>
    <given-names>K.J.A.</given-names>
   </name>
   <name>
    <surname>Lahtela-Kakkonen</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Naulaerts</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Op de Beeck</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Laukens</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway</article-title>
  <source>Biochem. Pharmacol.</source>
  <year>2016</year>
  <volume>109</volume>
  <fpage>48</fpage>
  <lpage>61</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bcp.2016.03.026</pub-id>
  <?supplied-pmid 27045103?>
  <pub-id pub-id-type="pmid">27045103</pub-id>
 </element-citation>
</ref>
